Clinical trial Recruiting at 6 sites Observational Ages 18 and up

Observational study of patients with spontaneous intracerebral hemorrhage

Official title: Multicentral Observational Prospective Cohort of Patients With Spontaneous Intracerebral Hemorrhage

Run by First Affiliated Hospital of Fujian Medical University · NCT06670456 · Data updated 2026-11-12

This study is looking at patients with spontaneous brain bleeding to see how they recover and what long-term effects they might have.

More Intracerebral Hemorrhage trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment3000 (estimated)
SponsorFirst Affiliated Hospital of Fujian Medical University
Academic / other
Locations6 sites (Fuzhou, Fujian and 5 other locations)
StatusRecruiting
StartedNovember 6, 2023
Main results expectedDecember 31, 2027
Study endsDecember 30, 2028
Registry record updatedNovember 1, 2024
Trial IDNCT06670456 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals diagnosed with spontaneous intracerebral hemorrhage who have not had any surgical interventions.

Probably not a fit

Patients with secondary intracerebral hemorrhage or severe comorbidities that limit life expectancy may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This multicentral, observational, prospective cohort study aims to gather data on patients diagnosed with spontaneous intracerebral hemorrhage (ICH) to assess early outcomes, complications, and long-term neurological and cognitive function. The study will include patients who have not undergone surgical intervention and will analyze cortical data for risk stratification and biomarkers. By following these patients over time, the study seeks to provide insights into the progression and recovery from ICH.

Why it matters

Potential benefit: If successful, this study could improve understanding of ICH outcomes and lead to better risk stratification and management strategies for patients.

How similar studies have gone: While observational studies on ICH exist, this specific approach focusing on cortical data and long-term outcomes is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Diagnosed with spontaneous intracerebral hemorrhage (ICH) through skull radiologic scans (CT or MRI);
* Underwent no surgical intervention;

Exclusion Criteria:

* Secondary intracerebral hemorrhage (with leading cause, e.g., Moyamoya disease, arteriovenous malformation, intracranial aneurysm, tumor, brain trauma)
* Pre-stroke life expectancy \< 1 year for severe comorbidities (e.g., Progressive malignant tumor, severe chronic heart failure \[NYHA: III-IV\], severe chronic obstructive pulmonary disease \[III-IV\], chronic kidney disease requiring hemodialysis)
* Severe dependency or incorporation to interview (e.g., pre-stroke mRS\>3, severe dementia, intractable mental disease)
* Unsuitable for inclusion in the study in the opinion of the investigator

Where it's running

  • First Affiliated Hospital of Fujian Medical University
    Fuzhou, Fujian, China
    Recruiting
  • Anxi County Hospital
    Quanzhou, Fujian, China
    Recruiting
  • Jinjiang Municipal Hospital
    Quanzhou, Fujian, China
    Recruiting
  • The Second Affiliated lospital of Xiamen Medical College
    Xiamen, Fujian, China
    Recruiting
  • Zhangzhou Municipal Hospital
    Zhangzhou, Fujian, China
    Recruiting
  • Liaocheng People's Hospital
    Liaocheng, Shandong, China
    Recruiting

Study contacts

  • Principal investigator: De-zhi Kang, MD — First Affiliated Hospital of Fujian Medical University
  • Study coordinator: De-zhi Kang, MD
  • Email: kdz99988@vip.sina.com
  • Phone: 86 15759413951

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.